312 related articles for article (PubMed ID: 29442622)
1. Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Akinyelu J; Singh M
J Nanosci Nanotechnol; 2018 Jul; 18(7):4478-4486. PubMed ID: 29442622
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
Cosco D; Federico C; Maiuolo J; Bulotta S; Molinaro R; Paolino D; Tassone P; Fresta M
Int J Nanomedicine; 2014; 9():2359-72. PubMed ID: 24876772
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
Basarkar A; Devineni D; Palaniappan R; Singh J
Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Anti-Cancer Activity of Benomyl Loaded Nanoparticles in Multidrug Resistant Cancer Cells.
Kini S; Bahadur D; Panda D
J Biomed Nanotechnol; 2015 May; 11(5):877-89. PubMed ID: 26349399
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DM; Dash S; Kishore V; Mandal TK
J Pharm Pharmacol; 2010 Apr; 62(4):422-9. PubMed ID: 20604830
[TBL] [Abstract][Full Text] [Related]
7. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin.
Jaimes-Aguirre L; Morales-Avila E; Ocampo-García BE; Medina LA; López-Téllez G; Gibbens-Bandala BV; Izquierdo-Sánchez V
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():743-751. PubMed ID: 28482586
[TBL] [Abstract][Full Text] [Related]
9. Stability-limit "Ouzo region" boundaries for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.
Beck-Broichsitter M
Int J Pharm; 2016 Sep; 511(1):262-266. PubMed ID: 27418569
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
11. Starburst Poly(amidoamine) Dendrimer Grafted Gold Nanoparticles as a Scaffold for Folic Acid-Targeted Plasmid DNA Delivery
Mbatha LS; Singh M
J Nanosci Nanotechnol; 2019 Apr; 19(4):1959-1970. PubMed ID: 30486936
[TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
[TBL] [Abstract][Full Text] [Related]
14. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
15. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier.
Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ
Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631
[TBL] [Abstract][Full Text] [Related]
17. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
Okassa LN; Marchais H; Douziech-Eyrolles L; Hervé K; Cohen-Jonathan S; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I
Eur J Pharm Biopharm; 2007 Aug; 67(1):31-8. PubMed ID: 17289360
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
19. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW
Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264
[TBL] [Abstract][Full Text] [Related]
20. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution.
Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M
Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
